Low cholesterol levels may be accompanied by solid tumors or hematological malignancies such as multiple myeloma. Decreased cholesterol levels have been reported in some experimental studies about chronic lymphocytic leukemia (CLL). It may be associated with tumoral cell metabolism. Herein, we examine blood lipid profiles of patients with newly diagnosed CLL (284 male, 276 female, mean age 64 ± 11 years) as defined by National Cancer Institute criteria. The control group consisted of 71 healthy subjects with mean age 55 ± 9 years (28 male, 43 females). 60% of patients with Binet A, while 25% were Binet C. Decreased levels of total cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL) were observed in patients with CL...
WOS: 000252538900007PubMed ID: 17874102Hypocholesterolemia is seen in solid tumors and some hematolo...
BACKGROUND AND OBJECTIVE: Abnormal blood lipid profiles have been reported in human malignancies. S...
Recommendations for dyslipidemia management aimed at reducing arterial occlusive events (AOEs) have ...
WOS: 000397053300006PubMed ID: 28259211Low cholesterol levels may be accompanied by solid tumors or ...
Background: This study was performed to investigate any association between cellular cholesterol hom...
Recent studies suggest there is a high incidence of elevated low-density lipoprotein (LDL) levels in...
OBJECTIVE: Alterations in plasma lipid profile and in intracellular cholesterol homoeostasis have be...
Serum levels of total cholesterol and triglycerides were studied in 202 patients affected by various...
Hypercholesterolemia is a known risk factor for many cancers, including Chronic Lymphocytic Leukemia...
Hypercholesterolemia is a known risk factor for many cancers, including Chronic Lymphocytic Leukemia...
Objectives: Chronic lymphocytic leukaemia (CLL) is associated with abnormalities of the B-Cell Recep...
Individuals suffering from cancer, including hematological malignancies, are at increased risk of ca...
Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The a...
Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The a...
Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The a...
WOS: 000252538900007PubMed ID: 17874102Hypocholesterolemia is seen in solid tumors and some hematolo...
BACKGROUND AND OBJECTIVE: Abnormal blood lipid profiles have been reported in human malignancies. S...
Recommendations for dyslipidemia management aimed at reducing arterial occlusive events (AOEs) have ...
WOS: 000397053300006PubMed ID: 28259211Low cholesterol levels may be accompanied by solid tumors or ...
Background: This study was performed to investigate any association between cellular cholesterol hom...
Recent studies suggest there is a high incidence of elevated low-density lipoprotein (LDL) levels in...
OBJECTIVE: Alterations in plasma lipid profile and in intracellular cholesterol homoeostasis have be...
Serum levels of total cholesterol and triglycerides were studied in 202 patients affected by various...
Hypercholesterolemia is a known risk factor for many cancers, including Chronic Lymphocytic Leukemia...
Hypercholesterolemia is a known risk factor for many cancers, including Chronic Lymphocytic Leukemia...
Objectives: Chronic lymphocytic leukaemia (CLL) is associated with abnormalities of the B-Cell Recep...
Individuals suffering from cancer, including hematological malignancies, are at increased risk of ca...
Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The a...
Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The a...
Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The a...
WOS: 000252538900007PubMed ID: 17874102Hypocholesterolemia is seen in solid tumors and some hematolo...
BACKGROUND AND OBJECTIVE: Abnormal blood lipid profiles have been reported in human malignancies. S...
Recommendations for dyslipidemia management aimed at reducing arterial occlusive events (AOEs) have ...